home / stock / cansd / cansd short
Short Information | Willow Biosciences (OTCMKTS:CANSD)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,460 |
Total Actual Volume | 8,724 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 3 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 173 |
Average Short Percentage | 17.55% |
Is there a CANSD Short Squeeze or Breakout about to happen?
See the CANSD Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-26-2019 | $0.9381 | $0.9381 | $0.9381 | $0.9381 | 1,000 | 1,000 | 100% |
06-20-2019 | $N/A | $1.096 | $N/A | $N/A | 60 | 60 | 100% |
06-19-2019 | $1.0573 | $1.096 | $1.096 | $1.0517 | 440 | 200 | 45.45% |
06-18-2019 | $1.212 | $1.083 | $1.212 | $1.083 | 1,900 | 1,900 | 100% |
06-07-2019 | $1.2705 | $1.28 | $1.28 | $1.2705 | 5,324 | 300 | 5.63% |
News, Short Squeeze, Breakout and More Instantly...
Willow Biosciences Company Name:
CANSD Stock Symbol:
OTCMKTS Market:
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share a significant development. The company has unveiled a noteworthy partnership with a Nasdaq-listed biopharmaceutical company, with a shared objective of forging precise and efficient manufacturi...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to announce a significant collaboration agreement between Willow Biosciences and Suanfarma. The partnership is focused on optimizing cell line productivity for manufacturing a high-volume anti-infec...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to announce some significant developments within the company. Willow Bioscience specializes in the production of ursodeoxycholic acid (UDCA), a vital pharmaceutical ingredient with extensive applica...